Molecular Targets in Salivary Gland Cancers: A Comprehensive Genomic Analysis of 118 Mucoepidermoid Carcinoma Tumors.

Maroun Bou ZerdanPrashanth Ashok KumarDaniel J ZaccariniJeffrey RossRichard HuangAbirami Sivapiragasam

Published in: Biomedicines (2023)

SGC are rare tumors with no FDA-approved treatment options. This large dataset reveals many opportunities for IO and targeted therapy contributing to the continuously increased precision in the selection of treatment for these patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes
combination therapy
single molecule
patient reported
replacement therapy
drug administration